Patients with thyroid disease may benefit from the Precision Peptide Genetic Test ($99 add-on after the first month), which identifies genetic variants affecting GLP-1 receptor sensitivity, FTO gene expression, and metabolic pathwaysinsights that help optimize medication choice and dose trajectory for safer, more effective weight loss
Add the first portion (say 3mL), remove the syringe, draw the remaining portion, and add it the same way, down the glass wall, slowly
Avoid Temperature Fluctuations: Consistent temperature is key
[3] Key Takeaways Comparable to injectable: 16.6% weight loss is similar to injectable Wegovy (14.9%) High responder rate: 76% of patients lost at least 5% of body weight Clinically meaningful: Half achieved 15%+ weight loss CV benefits preserved: Also approved for cardiovascular risk reduction The Bottom Line Oral Wegovy delivers weight loss results comparable to the injectableproving the pill form works just as well for most patients
[DOI] [PMC free article] [PubMed] [Google Scholar] 18.El-Haschimi K, Pierroz DD, Hileman SM, Bjrbaek C, Flier JS
In men whose low testosterone is specifically caused by excess body weight, clinical trials suggest GLP-1 drugs may raise testosterone by reducing the fat-driven hormonal suppression that is causing the deficit without introducing external testosterone or disrupting the body's own hormone-producing signals
